SCOPUS 정보 검색 플랫폼

Volumn 77, Issue 3, 2018, Pages 468-470

Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy

(11) Le Burel, Sébastien a Champiat, Stéphane b,c Routier, Emilie b Aspeslagh, Sandrine b Albiges, Laurence b Szwebel, Tali Anne d Michot, Jean Marie b Chretien, Pascale a Mariette, Xavier a,c,e,f Voisin, Anne Laure b Lambotte, Olivier a,c,e,f

a BICÊTRE HOSPITAL (France)

b INSTITUT GUSTAVE ROUSSY (France)

c INSERM (France)

d Institut Cochin (France)

e INSERM U1184 (France)

f INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE (France)

Author keywords

Autoantibodies; Autoimmune Diseases; Autoimmunity; Sj gren's Syndrome; Treatment

Indexed keywords

AUTOANTIBODY; IMMUNOLOGICAL ANTINEOPLASTIC AGENT;

AGED; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PROSPECTIVE STUDY; REGISTER;

AGED; ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL; AUTOANTIBODIES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; REGISTRIES;

EID: 85044424850 PISSN: 00034967 EISSN: 14682060 Source Type: Journal
DOI: 10.1136/annrheumdis-2016-210820 Document Type: Letter

Times cited : (59)

References (6)

1
- 84965032301
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- Boutros C, Tarhini A, Routier E, et al. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination. Nat Rev Clin Oncol 2016;13:473-86.
- (2016) Nat Rev Clin Oncol , vol.13 , pp. 473-486
- Boutros, C.¹ Tarhini, A.² Routier, E.³

2
- 84953309212
- Immune-related adverse events with immune checkpoint blockade: A comprehensive review
- Michot JM, Bigenwald C, Champiat S, et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 2016;54:139-48.
- (2016) Eur J Cancer , vol.54 , pp. 139-148
- Michot, J.M.¹ Bigenwald, C.² Champiat, S.³

3
- 84978959070
- Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab
- Cappelli LC, Gutierrez AK, Baer AN, et al. Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab. Ann Rheum Dis 2017;76:43-50.
- (2017) Ann Rheum Dis , vol.76 , pp. 43-50
- Cappelli, L.C.¹ Gutierrez, A.K.² Baer, A.N.³

4
- 85019333926
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- Menzies AM, Johnson DB, Ramanujam S, et al. Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab. Ann Oncol 2016. doi: 10.1093/annonc/mdw443. pii: mdw443.
- (2016) Ann Oncol
- Menzies, A.M.¹ Johnson, D.B.² Ramanujam, S.³

5
- 84964573640
- Management of immune checkpoint blockade dysimmune toxicities: A collaborative position paper
- Champiat S, Lambotte O, Barreau E, et al. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. Ann Oncol 2016;27:559-74.
- (2016) Ann Oncol , vol.27 , pp. 559-574
- Champiat, S.¹ Lambotte, O.² Barreau, E.³

6
- 84984663113
- Checkpoint immunotherapy: Good for cancer therapy, bad for rheumatic diseases
- Calabrese L, Velcheti V. Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases. Ann Rheum Dis 2017;76:1-3.
- (2017) Ann Rheum Dis , vol.76 , pp. 1-3
- Calabrese, L.¹ Velcheti, V.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.